Skip to main content
Clinical Trials/NCT05873283
NCT05873283
Completed
Not Applicable

Is Central Lymph Node Dissection Necessary in Suspected Papillary Thyroid Cancer and Papillary Thyroid Cancer?

Başakşehir Çam & Sakura City Hospital1 site in 1 country250 target enrollmentJune 12, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Papillary Thyroid Cancer
Sponsor
Başakşehir Çam & Sakura City Hospital
Enrollment
250
Locations
1
Primary Endpoint
Reaching 100 patients was the first target
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Papillary cancer is a disease that spreads through lymphatic ways and its treatment is surgery. We performed prophylactic central dissection in addition to bilateral total thyroidectomy in patients with bethesda 5 and bethesda 6 biopsy results. We evaluated the pathology results retrospectively.

Registry
clinicaltrials.gov
Start Date
June 12, 2020
End Date
March 24, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Başakşehir Çam & Sakura City Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • B5 and B6 biopsy results

Exclusion Criteria

  • lobectomy

Outcomes

Primary Outcomes

Reaching 100 patients was the first target

Time Frame: 18 months

100 patients

Study Sites (1)

Loading locations...

Similar Trials